Cohen Klingenstein’s CSX Corp CSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Hold
40,500
0.06% 126
2026
Q1
$1.66M Hold
40,500
0.05% 137
2025
Q4
$1.47M Hold
40,500
0.04% 144
2025
Q3
$1.44M Hold
40,500
0.05% 145
2025
Q2
$1.32M Hold
40,500
0.04% 147
2025
Q1
$1.19M Hold
40,500
0.04% 148
2024
Q4
$1.31M Hold
40,500
0.04% 148
2024
Q3
$1.4M Hold
40,500
0.05% 154
2024
Q2
$1.35M Hold
40,500
0.05% 152
2024
Q1
$1.5M Hold
40,500
0.06% 149
2023
Q4
$1.4M Hold
40,500
0.06% 148
2023
Q3
$1.25M Hold
40,500
0.06% 147
2023
Q2
$1.38M Hold
40,500
0.06% 146
2023
Q1
$1.21M Hold
40,500
0.06% 147
2022
Q4
$1.25M Hold
40,500
0.06% 149
2022
Q3
$1.08M Hold
40,500
0.06% 151
2022
Q2
$1.18M Hold
40,500
0.06% 148
2022
Q1
$1.52M Hold
40,500
0.06% 140
2021
Q4
$1.52M Hold
40,500
0.06% 142
2021
Q3
$1.2M Hold
40,500
0.05% 164
2021
Q2
$1.3M Hold
40,500
0.06% 165
2021
Q1
$1.3M Hold
40,500
0.06% 155
2020
Q4
$1.23M Hold
40,500
0.06% 156
2020
Q3
$1.05M Hold
40,500
0.06% 163
2020
Q2
$941K Hold
40,500
0.06% 167
2020
Q1
$774K Hold
40,500
0.06% 167
2019
Q4
$977K Hold
40,500
0.06% 169
2019
Q3
$935K Buy
+40,500
New +$943K 0.06% 167

Other funds holding CSX

Cohen Klingenstein's CSX Position: Q2 2026 in Review

Cohen Klingenstein held its CSX Corp (CSX) position steady in Q2 2026 at 40,500 shares worth $1.92M. The position accounts for 0.06% of the portfolio, ranked #126.

Cohen Klingenstein first reported a position in CSX in Q3 2019 and has held it in 28 quarters since. 860 funds tracked by Wall St. Rank hold CSX as of Q2 2026.

  • Cohen Klingenstein held 40,500 shares of CSX Corp worth $1.92M as of Q2 2026.
  • Cohen Klingenstein left its CSX Corp share count unchanged in Q2 2026.
  • CSX Corp made up 0.06% of Cohen Klingenstein's portfolio in Q2 2026, its #126 holding.
  • Cohen Klingenstein first reported a position in CSX Corp in Q3 2019 and has held it in 28 quarters since.
  • 860 funds tracked by Wall St. Rank held CSX Corp as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.